WEDNESDAY, April 29, 2020 (HealthDay News) — A potential vaccine against the new coronavirus shows promise and could begin human testing within a few weeks.
The vaccine was developed by researchers at Oxford University in the U.K. and appears to be effective in lab animals. If regulators give approval, a clinical trial involving more than 6,000 people could be launched by the end of May, The New York Times reported.
U.S. National Institutes of Health scientists tested the vaccine on six rhesus macaque monkeys last month and got good results. Despite being exposed to large amounts of the coronavirus, all of the monkeys were still healthy more than four weeks later.
If the human trials go well and the vaccine is approved for use, the Oxford team said they could have a few million doses of the vaccine available by September, far sooner than other vaccine projects, the Times reported.
Copyright © 2019 HealthDay. All rights reserved.
What is the Wuhan coronavirus?
Subscribe to our Newsletter and get the complete health program for a health you.